Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Sciformix Opens New Office in Manila

Published: Monday, August 12, 2013
Last Updated: Monday, August 12, 2013
Bookmark and Share
Company continues expansion with opening of new office to accommodate rapid growth.

Sciformix Corporation has announced the opening of their new offices located in Manila, the Philippines. The expansion into Manila comes as part of Sciformix‘s continued growth and provides the opportunity for the company to utilize the region’s extensive resource of talented medical professionals.

Philippine Labor and Employment Secretary, Rosalinda Baldoz, welcomed the move by Sciformix and the opportunity for medical professionals to remain in the Philippines with attractive salaries and career opportunities.

“Sciformix’s continued growth and success has created an opportunity for our expansion into Manila, which is an important piece of our strategy and global footprint. As a leading SPO, this move takes us forward with the goal of adding more than 200 highly skilled employees in the Philippines”, said Manish Vinayak Soman, Sciformix President and Chief Executive Officer (CEO).

Sciformix, recent winner of Frost & Sullivan’s Pharmaceutical Knowledge Process Outsourcing (KPO) Entrepreneurial Company of the Year award, has experienced remarkable growth to become an SPO, a sub-category of KPO specializing in life sciences.

The company’s investment in its people and technologies has enabled the business to deliver its clients differentiated services, resulting in rapid double digit revenue growth.

Sciformix has a unique positioning as a SPO, in that it combines deep expertise in workflow processes optimization with scientific knowledge, which delivers in line with their cost efficiency model.

This expansion into the Philippines also sees Sciformix as the first company based in Manila to undertake case management activities. A 135-strong team from Sciformix’s Philippines and India centers is supporting one of its Fortune 100 company clients that specializes in consumer healthcare, medical devices and diagnostics, and pharmaceuticals.

Sciformix, headquartered in the USA, with operations in India and the Philippines, partners with life science organizations through the entire drug development cycle to provide a full range of services from study design to post marketing surveillance and commercialization support.

Areas of specialization include Safety and Risk Management, Clinical Research & Post Approval Services, Medical Affairs, Scientific Writing and Regulatory Affairs.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 4,000+ scientific posters on ePosters
  • More than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Sciformix Awarded Best Safety & Risk Management Company
Sciformix Corporation has been recognized as the Best Safety & Risk Management Company in the 2016 International Life Sciences Awards.
Monday, August 22, 2016
Sciformix CEO Recognized as Most Talented Leader in Outsourcing
Sciformix is pleased to announce that Manish Vinayak Soman, President and CEO of Sciformix, has been named as one of the ‘Most Talented Leaders in the Outsourcing Industry’.
Tuesday, February 23, 2016
Scientific News
Making It Personal
Cancer vaccine linked to increased immune response against leukemia cells.
Gene Therapy Maintains Clotting Factor for Hemophilia Patients
Following a single gene therapy dose, the highest levels of an essential blood clotting factor IX were observed in hemophilia B patients.
BioCision Forms MedCision
The new company will focus on technologies for the management and automation of vital clinical processes.
First New HIV Vaccine Study for Seven Years Begins
South Africa hosts historic clinical trial of experimental HIV vaccine aiming to safely prevent HIV infection.
Study to Assess Shorter-Duration Antibiotics in Children
Physicians plan a clinical trial to evaluate whether short course anti-biotics are effective at treating CAP in children.
Cancer Gene Predicts Treatment Response in Leukaemia
Study indicates the patients suffering from a lethal for of acute myeloid leukemia may live longer when receiving milder chemotherapy drugs.
Injectable Biologic Therapy Reduces Triglycerides
Study finds first-of-its-kind therapy promising for patients with high triglycerides, cholesterol.
Testing Zika Vaccine in Humans Begins
The first of five planned clinical trials to test ZPIV vaccine in humans has begun.
Combination Therapy Improved Chemoresistance in Ovarian Cancer
The study demonstrates how an existing class of targeted therapies could be used to potentiate the tumor suppression induced by cisplatin.
Gene Therapy for Blistering Skin Disease Shows Promise
Grafting genetically altered skin onto patients’ chronic wounds marks the first time skin-based gene therapy has been demonstrated to be safe and effective in humans.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!